Market Capitalization (Millions $) |
10,786 |
Shares
Outstanding (Millions) |
57 |
Employees |
1,170 |
Revenues (TTM) (Millions $) |
670 |
Net Income (TTM) (Millions $) |
116 |
Cash Flow (TTM) (Millions $) |
107 |
Capital Exp. (TTM) (Millions $) |
28 |
Repligen Corp
Repligen Corp is a biotechnology company that specializes in the manufacture and supply of bioprocessing products and technologies. The company's product portfolio includes Protein A and G ligands, affinity chromatography resins, growth factor supplements for cell culture, and filtration products for virus and gene therapy production. Repligen Corp was founded in 1981 and is headquartered in Waltham, Massachusetts. The company's manufacturing facilities are located in Waltham, Massachusetts and Lund, Sweden. Repligen Corp serves customers in the biopharmaceutical and biotechnology industries worldwide. The company has a strong focus on the development of novel and innovative technologies that enhance productivity and efficiency in bioprocessing. This has led to the creation of several proprietary technologies such as the OPUS pre-packed chromatography columns and the ATF (Alternating Tangential Flow) system for high-density cell culture perfusion. One of Repligen Corp's key strengths is its ability to meet the stringent quality standards of the bioprocessing industry. The company is ISO 9001:2015 certified and adheres to Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) guidelines. Overall, Repligen Corp is an established player in the bioprocessing industry with a strong track record of innovation and quality. The company's focus on the development of new products and technologies that increase the efficiency and productivity of bioprocessing is expected to position it for continued growth and success in the future.
Company Address: 41 Seyon Street, Bldg. 1, Suite 100 Waltham 2453 MA
Company Phone Number: 250-0111 Stock Exchange / Ticker: NASDAQ RGEN
|